Scope 2018

TriNetX releases new algorithm to aid clinical trial patient identification

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/tonivaver)
(Image: Getty/tonivaver)

Related tags: Cancer, Oncology, Clinical trial

The global health research network TriNetX has developed a new chemotherapy lines of treatment identification algorithm to help researchers identify potential clinical trial patients.

The new algorithm is able to understand treatment patterns to deduce a patient's line of chemotherapy treatment, according to TriNetX, which announced the new offering at the SCOPE Summit last week in Orlando, FL.

“In clinical studies, researchers are probably looking at patients that are on their second or third or maybe even fourth line of treatment, as potential candidates for trials​,” explained Jennifer Haas, vice president of marketing, TriNetX.

The offering is the latest component of TriNetX’s platform, which provides users with de-identified patient data integrated from EMRs, tumor registries, unstructured pathology reports, and molecular genomics data. This information is mapped onto the company’s network and is available for query, enabling users to analyze patient populations and perform "what-if"​ analyses, the company explained.

As sponsors and CROs are going to look up and run their queries across our platform they now can leverage [the new] algorithm​,” Haas told us at the summit.

Also of particular interest to oncology research, Haas explained the platform’s “rate of arrival​” capabilities use predictive analytics to estimate the number of patients potentially available at a later date.

That’s really helpful when designing protocols, because you then know that there will still be a cohort that you could potentially recruit​,” she added.

TriNetX also this week announced that the Boston Children’s Hospital has joined its global health research network.

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more